Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts

Core Insights - Hims & Hers Health, Inc. (HIMS) experienced a decline of 2.3% in its stock price, closing at $47.12, which underperformed compared to the S&P 500's gain of 0.23% on the same day [1] - The company’s stock has seen a significant loss of 18.42% over the past month, contrasting with the Medical sector's gain of 5.57% and the S&P 500's gain of 3.57% [1] Earnings Projections - The upcoming earnings report for Hims & Hers Health, Inc. is scheduled for November 3, 2025, with projected earnings per share (EPS) of $0.09, indicating a 50.00% increase year-over-year [2] - Revenue is expected to reach $583.68 million, reflecting a 45.35% increase compared to the same quarter last year [2] Fiscal Year Estimates - For the entire fiscal year, Zacks Consensus Estimates predict an EPS of $0.59 and revenue of $2.35 billion, representing increases of +118.52% and +59.39% respectively from the previous year [3] - Recent adjustments to analyst estimates are crucial as they often indicate short-term business trends, with positive revisions suggesting a favorable business outlook [3] Valuation Metrics - Hims & Hers Health, Inc. has a Forward P/E ratio of 81.97, which is significantly higher than the industry average Forward P/E of 40.27 [6] - The company also has a PEG ratio of 3.34, which is comparable to the Medical Info Systems industry's average PEG ratio of 3.32 [7] Industry Ranking - The Medical Info Systems industry, part of the Medical sector, holds a Zacks Industry Rank of 57, placing it in the top 24% of over 250 industries [7] - The Zacks Industry Rank evaluates the performance of industry groups based on the average Zacks Rank of individual stocks, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [8]